Sulindac, a COX1/COX2 inhibitor, exhibits anti-tumorigenic effects in obesity-driven models of endometrioid endometrial cancer

被引：0
|
作者：
John, Catherine [1 ]
Zhao, Ziyi [1 ]
Shen, Xiaochang [1 ]
Deng, Boer [1 ]
Strauss, Isabella [1 ]
Zhou, Chunxiao [1 ]
Sherman, Mark [2 ]
Hursting, Stephen [1 ]
Bae-Jump, Victoria [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
[2] Mayo Clin Florida, Jacksonville, FL USA
来源：
GYNECOLOGIC ONCOLOGY | 2023年 / 176卷
关键词：
D O I：
10.1016/j.ygyno.2023.06.407
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2289
引用
收藏
页码：S309 / S309
页数：1
相关论文
共 14 条
  • [1] ONC201 has anti-tumorigenic effects in obesity-driven endometrial cancer
    Tucker, K.
    Staley, A.
    Pierce, S. R.
    Fan, Y.
    Yin, Y.
    Sun, W.
    Zhao, X.
    Zhang, Y.
    Lee, D.
    Prabhu, V.
    Zhou, C.
    Bae-Jump, V. L.
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 : 49 - 49
  • [2] Ascorbate exhibits anti-tumorigenic effects in pre-clinical models of endometrioid endometrial cancer
    John, Catherine
    Shen, Xiaochang
    Deng, Boer
    Zhao, Ziyi
    Zhou, Chunxiao
    Bae-Jump, Victoria
    Secord, Angeles Alvarez
    Batinic-Haberle, Ines
    Spasojevic, Ivan
    [J]. GYNECOLOGIC ONCOLOGY, 2023, 176 : S37 - S38
  • [3] Simvastatin has anti-tumorigenic effects in endometrial cancer via reversal of obesity-driven upregulation of lipid biosynthesis
    West, L.
    Clark, L. H.
    Pierce, S. R.
    Yin, Y.
    Fang, Z.
    Lee, D.
    Zhou, C.
    Bae-Jump, V. L.
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 149 : 16 - 16
  • [4] Maresin-1, a specialized-pro-resolving mediator of inflammation, demonstrates anti-tumorigenic activity in obesity-driven endometrial cancer (EC)
    John, Catherine
    Deng, Boer
    Shen, Xiaochang
    Zhao, Ziyi
    Sherman, Mark
    Milne, Ginger
    Hursting, Stephen
    Lee, Douglas
    Zhou, Chunxiao
    Bae-Jump, Victoria
    [J]. GYNECOLOGIC ONCOLOGY, 2023, 173 : S12 - S12
  • [5] Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer
    Schointuch, Monica N.
    Gilliam, Timothy P.
    Stine, Jessica E.
    Han, Xiaoyun
    Zhou, Chunxiao
    Gehrig, Paola A.
    Kim, Kenneth
    Bae-Jump, Victoria L.
    [J]. GYNECOLOGIC ONCOLOGY, 2014, 134 (02) : 346 - 355
  • [6] Ipatasertib, an oral AKT inhibitor, in combination with paclitaxel exhibits anti-proliferative and anti-tumorigenic effects in preclinical studies for endometrioid endometrial cancer: Endometrial cancer molecularly targeted therapy consortium
    Newton, Meredith
    Burkett, Wesley
    Zhao, Ziyi
    Secord, Angeles Alvarez
    Zhou, Chunxiao
    Bae-Jump, Victoria
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 166 : S125 - S126
  • [7] Ipatasertib, an oral AKT inhibitor, exhibits anti-proliferative and anti-tumorigenic effects in pre-clinical studies for endometrioid endometrial cancer: Endometrial Cancer Molecularly Targeted Therapy Consortium
    O'Donnell, Jillian
    Buckingham, Lindsey
    Hao, Tianran
    Secord, Angeles Alvarez
    Zhou, Chunxiao
    Bae-Jump, Victoria
    [J]. GYNECOLOGIC ONCOLOGY, 2021, 162 : S41 - S42
  • [8] Ipatasertib, an oral AKT inhibitor, in combination with Bevacizumab exhibits anti-tumorigenic effects in pre-clinical studies for endometrioid endometrial cancer: Endometrial Cancer Molecularly Targeted Therapy Consortium
    Newton, Meredith
    Burkett, Wesley
    Zhao, Ziyi
    Secord, Angeles Alvarez
    Zhou, Chunxiao
    Bae-Jump, Victoria
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 166 : S31 - S31
  • [9] Oleic acid, a monounsaturated fatty acid, exhibits anti-proliferative and anti-tumorigenic effects in pre-clinical studies for endometrioid endometrial cancer
    Newton, Meredith
    Suo, Hongyan
    Burkett, Wesley
    Zhao, Ziyi
    Zhou, Chunxiao
    Bae-Jump, Victoria
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 166 : S140 - S140
  • [10] Anti-Inflammatory Drug Use and Ovarian Cancer Risk by COX1/COX2 Expression and Infiltration of Tumor-Associated Macrophages
    Barnard, Mollie E.
    Hecht, Jonathan L.
    Rice, Megan S.
    Gupta, Mamta
    Harris, Holly R.
    Eliassen, A. Heather
    Rosner, Bernard A.
    Terry, Kathryn L.
    Tworoger, Shelley S.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (12) : 1509 - 1517
12